Author:
Leighl Natasha B,Hellmann Matthew D,Hui Rina,Carcereny Enric,Felip Enriqueta,Ahn Myung-Ju,Eder Joseph Paul,Balmanoukian Ani S,Aggarwal Charu,Horn Leora,Patnaik Amita,Gubens Matthew,Ramalingam Suresh S,Lubiniecki Gregory M,Zhang Jin,Piperdi Bilal,Garon Edward B
Subject
Pulmonary and Respiratory Medicine
Reference29 articles.
1. SEER Cancer Statistics Review, 1975-2015;Noone,2018
2. Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer;Reck;Immunotherapy,2018
3. Factors associated with better overall survival in patients with previously treated, PD-L1–expressing, advanced NSCLC: multivariate analysis of KEYNOTE-010;Herbst,2017
4. Pembrolizumab for the treatment of non–small-cell lung cancer;Garon;N Engl J Med,2015
5. Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer;Chatterjee;Ann Oncol,2016
Cited by
150 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献